BLOCK LISTING SIX MONTHLY RETURN

Summary by AI BETAClose X

JSC Halyk Bank of Kazakhstan reports on their Global Depository Receipts (GDRs) offering for the period from March 31, 2025, to September 30, 2025. The balance of unallotted securities from the previous return was 123,494,989 GDRs. The block scheme has not increased since the last return, remaining at 0 GDRs. During this period, -771,689 securities were issued/allotted. Consequently, the balance of securities not yet issued/allotted at the end of the period is 124,266,678 GDRs.

Disclaimer*

JSC Halyk Bank
03 October 2025
 

BLOCK LISTING SIX MONTHLY RETURN

 

 

Date: 03 October 2025

 

Name of applicant:

Joint Stock Company Halyk Bank of Kazakhstan

Name of scheme:

Offering of Global Depository Receipts (GDRs)

Period of return:                                           From:

31 March 2025              To:     30 September 2025

Balance of unallotted securities under scheme(s) from previous return:

123,494,989 GDRs

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

0 GDRs

Less:  Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G):

-771,689 GDRs

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

124,266,678 GDRs

 

Name of contact:

Mira Tiyanak,

Head, Financial Institutions and International Relations Division

Telephone number of contact:

+7 727 259 04 30

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings